SCHEMBL27440338

SCHEMBL27440338

CC1CCN(c2cc(OCc3ccccc3)cc(Cl)n2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.49
▸ LMNA P02545 4/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ KDM4E B2RXH2 4/20 0.46
▸ OGA O60502 1/20 0.46
▸ HRH4 Q9H3N8 1/20 0.44
▸ ACHE P22303 3/20 0.43
▸ MAPT P10636 4/20 0.42
▸ HTT P42858 3/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ PRMT5 O14744 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ HRH3 Q9Y5N1 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16037235 0.83 PRMT5 (0.51) ALDH1A1KDM4EMAPTHTTPRMT5
SCHEMBL26695651 0.82 SPHK1 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL29998568 0.80 CKS1B (0.57) KMT2APRMT5L3MBTL1
SCHEMBL27448755 0.80 CKS1B (0.57) KMT2APRMT5L3MBTL1
SCHEMBL27440977 0.79 KDM4E (0.53) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL26077367 0.79 ALDH1A1 (0.54) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL27440444 0.78 LMNA (0.44) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL25961451 0.76 ALDH1A1 (0.44) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL8550828 0.76 ALOX5 (0.56) LMNASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL26077251 0.76 KIT (0.53) ALDH1A1LMNAKDM4EHRH4ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) 2024-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF KDM1A, TET1, KDM3A ALDH1A1 460/4885LMNA 1527/4885SMN1; SMN2 1994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback